TD Cowen lowered the firm’s price target on Avantor (AVTR) to $28 from $31 and keeps a Buy rating on the shares. The firm said Q3 was better than expected save for the significant weakness in Semis. Bioprocess looked good, Lab saw modest improvement with strong cost out and FCF.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTR: